Reata Pharmaceuticals RETA

$ 172.36 0.0%

Quarterly report 2023-Q1
added 05-10-2023

Reata Pharmaceuticals Financial Statements 2011-2024 | RETA

Annual Financial Statements Reata Pharmaceuticals

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	1.64 B	1.02 B	3.49 B	5.9 B	2.13 B	694 M	495 M	-	-	-	-	-
Shares	36.5 M	36.3 M	33.7 M	30.4 M	27.7 M	23.9 M	19.8 M	-	-	-	-	-
Historical Prices	45	28.1	104	219	79.8	28.5	24.9	-	-	-	-	-
Net Income	-312 M	-297 M	-248 M	-290 M	-80.5 M	-47.7 M	-6.23 M	-1.45 M	689 K	-35.1 M	-	-
Revenue	2.22 M	11.5 M	9.02 M	26.5 M	53.6 M	48.1 M	49.9 M	50.3 M	52 M	51.2 M	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-97.9 M	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	6.56 M	14.9 M	11.2 M	6.18 M	1.45 M	-	-	-	-	-	-
EBITDA	1.13 M	1.2 M	1.14 M	-284 M	-76.4 M	-46.5 M	-6.2 M	1.48 M	6.14 M	-7.46 M	-	-
Operating Expenses	280 M	256 M	235 M	187 M	130 M	95 M	56.7 M	50.7 M	48.3 M	-	-	-
General and Administrative Expenses	109 M	99 M	75.1 M	58.3 M	32.7 M	23.3 M	16.6 M	13.7 M	11.5 M	13.4 M	-	-

All numbers in USD currency

Quarterly Income Statement Reata Pharmaceuticals

	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	36.9 M	-	36.5 M	36.5 M	36.4 M	-	36.4 M	36.3 M	36.2 M	-	33.7 M	33.3 M	33.2 M	-	30.1 M	30.1 M	29.8 M	-	28.7 M	26.2 M	26.2 M	-	24.8 M	22.4 M	22.4 M	-	22.3 M	18.6 M	16 M	-	16 M	16 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-116 M	-	-79 M	-73.6 M	-73.8 M	-	-71.8 M	-72.7 M	-67.5 M	-65.8 M	-65.5 M	-67.6 M	-48.9 M	-187 M	-39.7 M	-34.4 M	-29.2 M	-25.6 M	-30.8 M	-28.2 M	4.08 M	-16.7 M	-12.3 M	-11.6 M	-7.1 M	-4.14 M	-897 K	-936 K	-258 K	-1.75 M	633 K	-1.7 M	1.36 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	195 K	-	540 K	762 K	914 K	-	7.39 M	2.22 M	944 K	3.19 M	1.4 M	3.07 M	1.35 M	2.67 M	8.24 M	7.83 M	7.77 M	8.45 M	5.18 M	7.57 M	32.4 M	9.96 M	12.6 M	12.8 M	12.7 M	12.5 M	12.6 M	12.4 M	12.4 M	12.5 M	12.5 M	12.4 M	12.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	1.92 M	-	-	-80 K	-33 K	-	1.84 M	1.77 M	1.71 M	-	1.67 M	5.64 M	5.87 M	-	2.39 M	2.41 M	2.4 M	-	2.36 M	903 K	509 K	-	484 K	468 K	5 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	288 K	-	272 K	273 K	308 K	-	320 K	287 K	274 K	-	289 K	284 K	278 K	-	258 K	232 K	170 K	-	105 K	105 K	101 K	-	98 K	109 K	130 K	-	170 K	179 K	188 K	-	486 K	529 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	111 M	-	71 M	64.7 M	65 M	-	65.5 M	62.4 M	55.9 M	57.2 M	55.8 M	53.7 M	68.7 M	187 M	46.8 M	41.5 M	36.3 M	33.4 M	34.7 M	34.2 M	28.1 M	26.5 M	24.6 M	24 M	19.9 M	16.7 M	13.5 M	13.8 M	12.7 M	13.1 M	12 M	13.6 M	12 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	54.9 M	-	27.3 M	25.1 M	24.8 M	-	25.7 M	22 M	20.7 M	-	18.3 M	16.6 M	20.8 M	-	14.3 M	11.7 M	10 M	-	7.49 M	10.7 M	6.63 M	-	6.15 M	5.99 M	5.17 M	-	4.04 M	4.54 M	3.21 M	-	2.98 M	3.37 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency